)
Concord Biotech (CONCORDBIO) investor relations material
Concord Biotech Q3 25/26 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Q3 FY26 revenue grew 14% year-over-year, led by strong API segment performance and improved order execution following regulatory approvals.
WHO GMP certification for the injectable facility enables domestic and emerging market sales, with peak revenue potential estimated at INR 600 crore.
New subsidiaries established in India and the US, including Concord Lifegen and Stellon Biotech, to strengthen global expansion and commercialization.
Unaudited standalone and consolidated financial results for Q3 and nine months ended December 31, 2025, were approved without audit qualifications.
FY26 expected to remain below historical averages, but normalization and growth are anticipated from FY27 onward.
Financial highlights
Q3 FY26 revenue: INR 278 crore (14% YoY growth); nine-month revenue: INR 729 crore (5% YoY decline); consolidated Q3 revenue: INR 277.8 crore.
API revenue in Q3: INR 219 crore (24% YoY growth); Formulation revenue: INR 58 crore (down from INR 68 crore YoY).
Q3 EBITDA: INR 99 crore (margin 35.6%), impacted by startup costs; normalized margin at 40%.
Q3 profit after tax: INR 64 crore (Q3 FY25: INR 76 crore), affected by new labor costs and lower other income.
Zero debt; cash and equivalents at INR 350 crore as of December 2025.
Outlook and guidance
Q4 expected to be stronger, with gradual normalization of margins as injectables scale up.
Management expects continued demand growth, higher order inflows, and increased CDMO engagements, supported by positive trade dynamics and regulatory clarity.
Historical CAGR of 18% targeted, with potential to reach 25% as new growth drivers mature.
The company continues to monitor regulatory changes, especially regarding the new Labour Codes.
Next Concord Biotech earnings date
Next Concord Biotech earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage
)
)